On the discovery of the genetic association of Apolipoprotein E genotypes and common late-onset Alzheimer disease

Journal of Alzheimer's Disease

Volumn 9, Issue SUPPL. 3, 2006, Pages 361-366

  Roses, Allen D ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; DNA; GLUCOSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; ROSIGLITAZONE;

ALLELE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL METABOLISM; CHROMOSOME 19Q; CHROMOSOME 21; CLINICAL TRIAL; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DRUG EFFICACY; GENE MAPPING; GENETIC LINKAGE; GENOTYPE; GLUCOSE UTILIZATION; HUMAN; HUMAN GENOME; KNOCKOUT MOUSE; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; MOUSE; NERVE CELL; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHASE 2 CLINICAL TRIAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEOMICS; REVIEW; THERMOGRAPHY;

EID: 33645776373     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/jad-2006-9s340     Document Type: Review

References (37)

1. W. Strittmatter, A. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G. Salvesen and A. Roses, Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proceedings of the National Academy of Sciences of the United States of America 90 (2004), 1977-1981.
2. A. Saunders, W. Strittmatter, D. Schmechel, P. George-Hyslop, M. Pericak-Vance, S. Joo, B. Rosi, J. Gusella, D. Crapper-MacLachlan, M. Alberts, C. Hulette, B. Crain, D. Goldgaber and A. Roses, Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease, Neurology 43 (1993), 1467-1472.
3. E. Corder, A. Saunders, W. Strittmatter, D. Schmechel, P. Gaskell, G. Small, A. Roses, J. Haines and M. Pericak-Vance, Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science 261 (1993), 921-923.
4. Heyman, W. Wilkinson, B. Hurwitz, D. Schmechel, A. Sigmon, T. Weinberg, M. Helms and M. Swift, Alzheimer's disease: genetic aspects and associated clinical disorders, Annals of Neurology 14 (1983), 507-515.
5. A. Roses, M. Pericak-Vance, L. Yamaoka, C. Haynes, M. Speer, P. Gaskell, W. Hung, C. Clark, A. Heyman, J. Trofatter, N. Earl, J. Gilbert, J. Lee, M. Alberts, D. Dawson, R. Bartlett, T. Siddique, J. Vance and P. Conneally, Linkage studies in familial Alzheimer's disease, Progress in Clinical & Biological Research 317 (1989), 201-215.
6. C. Hulette, K. Welsh-Bohmer, B. Crain, M. Szymanski, N. Sinclaire and A. Roses, Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer's Disease Research Center experience, Archives of Pathology & Laboratory Medicine 121 (1997), 615-618.
7. E. Sajdel-Sulkowska and C. Marotta, Alzheimer's disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex, Science 225 (1984), 947-949.
8. M. Pericak-Vance, J. Bebout, P. Gaskell, L. Yamaoka, W. Hung, M. Alberts, A. Walker, R. Bartlett, C. Haynes, K. Welsh, N. Earl, A. Heyman, C. Clark and A. Roses, Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage, American Journal of Human Genetics 48 (1991), 1034-1050.
9. M. Pericak-Vance, P. St George-Hyslop, P. Gaskell, J. Growdon, B. Crain, C. Hulette, J. Gusella, L. Yamaoka, R. Tanzi, A. Roses and J. Haines, Linkage analysis in familial Alzheimer disease: description of the Duke and Boston data sets, Genetic Epidemiology 10 (1993), 361-364.
10. A. Goate, M. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, L. Fidani, L. Giuffra, A. Haynes, N. Irving, L. James, R. Mant, P. Newton, K. Rooke, P. Roques, C. Talbot, M. Pericak-Vance, A. Roses, R. Williamson, M. Rossor, M. Owen and J. Hardy, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature 349 (1991), 704-706.
11. G. Schellenberg, T. Bird, E. Wijsman, H. Orr, L. Anderson, E. Nemens, J. White, L. Bonnycastle, J. Weber, M. Alonso, H. Potter, L. Heston and G. Martin, Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14, Science 258 (1992), 668-671.
12. A. Saunders and M. Seldin, The syntenic relationship of proximal mouse chromosome 7 and the myotonic dystrophy gene region on human chromosome 19q, Genomics 6 (1990), 324-332.
13. Editorial, Society for Neuroscience Annual Meeting Report: Roses supposes that APOE predisposes to amyloidosis, Journal of NIH Research (December 1992).
14. A. Roses, A. Saunders, W. Strittmatter, M. Pericak-Vance and D. Schmechel, Apolipoprotein E-E4 isoform is associated with susceptibility to Alzheimer's disease, Neurology 43 (1993), 192A.
15. M. Waldholz, One of the main enigmas of the Alzhiemer's disease is said to be untangled, Wall Street Journal (Nov. 1993).
16. S. Han, G. Einstein, K. Weisgraber, W. Strittmatter, A. Saunders, M. Pericak-Vance, A. Roses and D. Schmechel, Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study, Journal of Neuropathology & Experimental Neurology 53 (1994), 535-544.
17. B. Teter, P. Xu, J. Gilbert, A. Roses, D. Galasko and G. Cole, Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal culture, Journal of Neurochemistry 73 (1999), 2613-2616.
18. S. Chapman, T. Sabo, A. Roses and D. Michaelson, Reversal of presynaptic deficits of apolipoprotein E-deficient mice in human apolipoprotein E transgenic mice, Neuroscience 97 (2000), 419-424.
19. G. Einstein, V. Patel, P. Bautista, M. Kenna, L. Melone, R. Fader, K. Karson, S. Mann, A. Saunders, C. Hulette, D. Mash, A. Roses and D. Schmechel, Intraneuronal ApoE in human visual cortical areas reflects the staging of Alzheimer disease pathology, Journal of Neuropathology & Experimental Neurology 57 (1998), 1190-1201.
20. P. Xu, J. Gilbert, H. Qiu, T. Rothrock-Christian, D. Settles, A. Roses and D. Schmechel, Regionally specific neuronal expression of human APOE gene in transgenic mice, Neuroscience Letters 246 (1998), 65-68.
21. Roses, J. Gilbert, P. Xu, P. Sullivan, B. Popko, D. Burkhart, T. Christian-Rothrock, A. Saunders, N. Maeda and D. Schmechel, Cis-acting human ApoE tissue expression element is associated with human pattern of intraneuronal ApoE in transgenic mice, Neurobiology of Aging 19 (1998), S53-S58.
22. K. Williams, V. Pye, A. Saunders, A. Roses and P. Armati, Apolipoprotein E uptake and low-density lipoprotein receptor-related protein expression by the NTera2/D1 cell line: a cell culture model of relevance for late-onset Alzheimer's disease, Neurobiology of Disease 4 (1997), 58-67.
23. D. Huang, M. Goedert, R. Jakes, K. Weisgraber, C. Garner, A. Saunders, M. Pericak-Vance, D. Schmechel, A. Roses and W. Strittmatter, Isoform-specific interactions of apolipoprotein E with the microtubule-associated protein MAP2c: implications for Alzheimer's disease, Neuroscience Letters 182 (1994), 55-58.
24. W. Strittmatter, A. Saunders, M. Goedert, K. Weisgraber, L. Dong, R. Jakes, D. Huang, M. Pericak-Vance, D. Schmechel and A. Roses, Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease, Proceedings of the National Academy of Sciences of the United States of America 91 (1994), 11183-11186.
25. E. Reiman, R. Caselli, L. Yun, K. Chen, D. Bandy, S. Minoshima, S. Thibodeau and D. Osborne, Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E, New England Journal of Medicine 334 (1996), 752-758.
26. G. Small, L. Ercoli, D. Silverman, S. Huang, S. Komo, S. Bookheimer, H. Lavretsky, K. Miller, P. Siddarth, N. Rasgon, J. Mazziotta, S. Saxena, H. Wu, M. Mega, J. Cummings, A. Saunders, M. Pericak-Vance, A. Roses, J. Barrio and M. Phelps, Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease, Proceedings of the National Academy of Sciences of the United States of America 97 (2000), 6037-6042.
27. A. Saunders, M. Trowers, R. Shimkets, S. Blakemore, D. Crowther, T. Mansfield, D. Wallace, W. Strittmatter and A. Roses, The role of apolipoprotein E in Alzheimer's disease: pharmacogenomic target selection, Biochimica et Biophysica Acta 1502 (2000), 85-94.
28. A. Roses and M. Pangalos, Drug development and Alzheimer disease, American Journal of Geriatric Psychiatry 11 (2003), 123-130.
29. G. Watson and S. Craft, The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment, CNS Drugs 17 (2003), 27-45.
30. S. Craft and G. Watson, Insulin and neurodegenerative disease: shared and specific mechanisms, Lancet Neurology 3 (2004), 169-178.
31. G. Watson and S. Craft, Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease, European Journal of Pharmacology 490 (2004), 97-113.
32. A. Roses, Causes or consequences of inflammation and pathological signs of Alzheimer disease, Neurobiology of Aging 21 (2000), 423-425.
33. J. Shorter and S. Lindquist, Prions as asaptive conduits of memory and inheritance, Nature Reviews Genetics 6 (2005), 435-450.
34. M.E. Risner, A.M. Saunders, J.F.B. Altman, G.C. Ormandy, S. Craft, I.M. Foley, M. Zyartau-Hind, D.A. Hosford and A.D. Roses, Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's Disease, The Pharrnucogenetics Journal, advance online publication 31 January 2006; doi:10.1038/sj.tpj.6500369.
35. Y. Huang, X.Q. Liu, T. Wyss-Coray, W.J. Brecht, D.A. Sanan and R.W. Mahley, Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons, Proc Natl Acad Sci USA 98 (2001), 8838-8843.
36. S. Chang, T.R. Ma, R.D. Miranda, M.E. Balestra, R.W. Mahley and Y. Huang, Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity, Proc Natl Acad Sci USA 102 (2005), 18694-18699.
37. A.D. Roses, A.M. Saunders, Y. Huang, J. Strum, K.H. Weisgraber and R.W. Mahley, Complex disease-associated pharmacogenetics: drug efficacy, drug safety, and confirmation of a pathogenetic hypothesis (Alzheimer's disease), The Pharmacogenomics Journal (2006), in press.